{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:07:33Z","timestamp":1784966853533,"version":"3.55.0"},"reference-count":44,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,7,1]]},"DOI":"10.1248\/bpb.b20-00088","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T22:16:15Z","timestamp":1593555375000},"page":"1088-1095","source":"Crossref","is-referenced-by-count":38,"title":["Application of Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids as a Model of Epithelial Damage and Fibrosis in Inflammatory Bowel Disease"],"prefix":"10.1248","volume":"43","author":[{"given":"Daichi","family":"Onozato","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Akagawa","sequence":"additional","affiliation":[{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Kida","sequence":"additional","affiliation":[{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Hashita","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University"},{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Iwao","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University"},{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamihide","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University"},{"name":"Educational Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Holmberg FE, Seidelin JB, Yin X, Mead BE, Tong Z, Li Y, Karp JM, Nielsen OH. Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease. EMBO Mol. Med.<\/i>, 9<\/b>, 558\u2013570 (2017).","DOI":"10.15252\/emmm.201607260"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, Geboes K, Ceuppens JL, Rutgeerts P. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn\u2019s disease. Am. J. Gastroenterol.<\/i>, 97<\/b>, 2000\u20132004 (2002).","DOI":"10.1111\/j.1572-0241.2002.05914.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med.<\/i>, 51<\/b>, 289\u2013298 (2000).","DOI":"10.1146\/annurev.med.51.1.289"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Satsu H, Ishimoto Y, Nakano T, Mochizuki T, Iwanaga T, Shimizu M. Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via<\/i> tumor necrosis factor-alpha. Exp. Cell Res.<\/i>, 312<\/b>, 3909\u20133919 (2006).","DOI":"10.1016\/j.yexcr.2006.08.018"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Okamoto R, Watanabe M. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease. J. Gastroenterol.<\/i>, 51<\/b>, 11\u201321 (2016).","DOI":"10.1007\/s00535-015-1098-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kaser A, Niederreiter L, Blumberg RS. Genetically determined epithelial dysfunction and its consequences for microflora-host interactions. Cell. Mol. Life Sci.<\/i>, 68<\/b>, 3643\u20133649 (2011).","DOI":"10.1007\/s00018-011-0827-y"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann. N. Y. Acad. Sci.<\/i>, 1072<\/b>, 242\u2013252 (2006).","DOI":"10.1196\/annals.1326.017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M. Epithelial tight junctions in intestinal inflammation. Ann. N. Y. Acad. Sci.<\/i>, 1165<\/b>, 294\u2013300 (2009).","DOI":"10.1111\/j.1749-6632.2009.04062.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol. Clin. North Am.<\/i>, 28<\/b>, 255\u2013281, vii (1999).","DOI":"10.1016\/S0889-8553(05)70056-X"},{"key":"10","unstructured":"10) Latella G, Sferra R, Speca S, Vetuschi A, Gaudio E. Can we prevent, reduce or reverse intestinal fibrosis in IBD? Eur. Rev. Med. Pharmacol. Sci.<\/i>, 17<\/b>, 1283\u20131304 (2013)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Johnson LA, Rodansky ES, Haak AJ, Larsen SD, Neubig RR, Higgins PD. Novel Rho\/MRTF\/SRF inhibitors block matrix-stiffness and TGF-beta-induced fibrogenesis in human colonic myofibroblasts. Inflamm. Bowel Dis.<\/i>, 20<\/b>, 154\u2013165 (2014).","DOI":"10.1097\/01.MIB.0000437615.98881.31"},{"key":"12","unstructured":"12) Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C. Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am. J. Pathol.<\/i>, 179<\/b>, 2660\u20132673 (2011)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Andoh A, Bamba S, Brittan M, Fujiyama Y, Wright NA. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol. Ther.<\/i>, 114<\/b>, 94\u2013106 (2007).","DOI":"10.1016\/j.pharmthera.2006.12.004"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am. J. Physiol.<\/i>, 277<\/b>, C183\u2013C201 (1999).","DOI":"10.1152\/ajpcell.1999.277.2.C183"},{"key":"15","unstructured":"15) Latella G, Caprilli R, Travis S. In favour of early surgery in Crohn\u2019s disease: a hypothesis to be tested. J. Crohns Colitis<\/i>, 5<\/b>, 1\u20134 (2011)."},{"key":"16","unstructured":"16) Hahn S, Nam MO, Noh JH, Lee DH, Han HW, Kim DH, Hahm KB, Hong SP, Yoo JH, Yoo J. Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis, perspective. Sci. Rep.<\/i>, 7<\/b>, 2435 (2017)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF, Zachos NC. A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions. Sci. Rep.<\/i>, 7<\/b>, 45270 (2017).","DOI":"10.1038\/srep46790"},{"key":"18","unstructured":"18) Rodansky ES, Johnson LA, Huang S, Spence JR, Higgins PD. Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs. Exp. Mol. Pathol.<\/i>, 98<\/b>, 346\u2013351 (2015)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Dedhia PH, Bertaux-Skeirik N, Zavros Y, Spence JR. Organoid models of human gastrointestinal development and disease. Gastroenterology.<\/i>, 150<\/b>, 1098\u20131112 (2016).","DOI":"10.1053\/j.gastro.2015.12.042"},{"key":"20","unstructured":"20) Eglen RM, Randle DH. Drug discovery goes three-dimensional: Goodbye to flat high-throughput screening? Assay Drug Dev. Technol.<\/i>, 13<\/b>, 262\u2013265 (2015)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Liu F, Huang J, Ning B, Liu Z, Chen S, Zhao W. Drug discovery via<\/i> human-derived stem cell organoids. Front. Pharmacol.<\/i>, 7<\/b>, 334 (2016).","DOI":"10.3389\/fphar.2016.00334"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ, Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro<\/i> without a mesenchymal niche. Nature<\/i>, 459<\/b>, 262\u2013265 (2009).","DOI":"10.1038\/nature07935"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD, Clevers H. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology.<\/i>, 141<\/b>, 1762\u20131772 (2011).","DOI":"10.1053\/j.gastro.2011.07.050"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, Tolle K, Hoskins EE, Kalinichenko VV, Wells SI, Zorn AM, Shroyer NF, Wells JM. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.<\/i> Nature<\/i>, 470<\/b>, 105\u2013109 (2011).","DOI":"10.1038\/nature09691"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Takahashi Y, Sato S, Kurashima Y, Yamamoto T, Kurokawa S, Yuki Y, Takemura N, Uematsu S, Lai CY, Otsu M, Matsuno H, Osawa H, Mizushima T, Nishimura J, Hayashi M, Yamaguchi T, Kiyono H. A refined culture system for human induced pluripotent stem cell-derived intestinal epithelial organoids. Stem Cell Reports<\/i>, 10<\/b>, 314\u2013328 (2018).","DOI":"10.1016\/j.stemcr.2017.11.004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Uchida H, Machida M, Miura T, Kawasaki T, Okazaki T, Sasaki K, Sakamoto S, Ohuchi N, Kasahara M, Umezawa A, Akutsu H. A xenogeneic-free system generating functional human gut organoids from pluripotent stem cells. JCI Insight<\/i>, 2<\/b>, e86492 (2017).","DOI":"10.1172\/jci.insight.86492"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Onozato D, Yamashita M, Nakanishi A, Akagawa T, Kida Y, Ogawa I, Hashita T, Iwao T, Matsunaga T. Generation of intestinal organoids suitable for pharmacokinetic studies from human induced pluripotent stem cells. Drug Metab. Dispos.<\/i>, 46<\/b>, 1572\u20131580 (2018).","DOI":"10.1124\/dmd.118.080374"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Onozato D, Yamashita M, Fukuyama R, Akagawa T, Kida Y, Koeda A, Hashita T, Iwao T, Matsunaga T. Efficient generation of cynomolgus monkey induced pluripotent stem cell-derived intestinal organoids with pharmacokinetic functions. Stem Cells Dev.<\/i>, 27<\/b>, 1033\u20131045 (2018).","DOI":"10.1089\/scd.2017.0216"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Munera JO, Sundaram N, Rankin SA, Hill D, Watson C, Mahe M, Vallance JE, Shroyer NF, Sinagoga KL, Zarzoso-Lacoste A, Hudson JR, Howell JC, Chatuvedi P, Spence JR, Shannon JM, Zorn AM, Helmrath MA, Wells JM. Differentiation of human pluripotent stem cells into colonic organoids via<\/i> transient activation of BMP signaling. Cell Stem Cell<\/i>, 21<\/b>, 51\u201364.e6 (2017).","DOI":"10.1016\/j.stem.2017.05.020"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Bates RC, Mercurio AM. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell<\/i>, 14<\/b>, 1790\u20131800 (2003).","DOI":"10.1091\/mbc.e02-09-0583"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kalluri R, Weinberg RA. The basics of epithelial\u2013mesenchymal transition. J. Clin. Invest.<\/i>, 119<\/b>, 1420\u20131428 (2009).","DOI":"10.1172\/JCI39104"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Foulke-Abel J, In J, Yin J, Zachos NC, Kovbasnjuk O, Estes MK, de Jonge H, Donowitz M. Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology. Gastroenterology<\/i>, 150<\/b>, 638\u2013649.e8 (2016).","DOI":"10.1053\/j.gastro.2015.11.047"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Zachos NC, Kovbasnjuk O, Foulke-Abel J, In J, Blutt SE, de Jonge HR, Estes MK, Donowitz M. Human enteroids\/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J. Biol. Chem.<\/i>, 291<\/b>, 3759\u20133766 (2016).","DOI":"10.1074\/jbc.R114.635995"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Crespo M, Vilar E, Tsai SY, Chang K, Amin S, Srinivasan T, Zhang T, Pipalia NH, Chen HJ, Witherspoon M, Gordillo M, Xiang JZ, Maxfield FR, Lipkin S, Evans T, Chen S. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nat. Med.<\/i>, 23<\/b>, 878\u2013884 (2017).","DOI":"10.1038\/nm.4355"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Finkbeiner SR, Freeman JJ, Wieck MM, El-Nachef W, Altheim CH, Tsai YH, Huang S, Dyal R, White ES, Grikscheit TC, Teitelbaum DH, Spence JR. Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids. Biol. Open<\/i>, 4<\/b>, 1462\u20131472 (2015).","DOI":"10.1242\/bio.013235"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Dharmani P, Leung P, Chadee K. Tumor necrosis factor-alpha and Muc2 mucin play major roles in disease onset and progression in dextran sodium sulphate-induced colitis. PLoS ONE<\/i>, 6<\/b>, e25058 (2011).","DOI":"10.1371\/journal.pone.0025058"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Suzuki K, Murano T, Shimizu H, et al.<\/i> Single cell analysis of Crohn\u2019s disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties. J. Gastroenterol.<\/i>, 53<\/b>, 1035\u20131047 (2018).","DOI":"10.1007\/s00535-018-1437-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Capaldo CT, Nusrat A. Cytokine regulation of tight junctions. Biochim. Biophys. Acta<\/i>, 1788<\/b>, 864\u2013871 (2009).","DOI":"10.1016\/j.bbamem.2008.08.027"},{"key":"39","unstructured":"39) Edelblum KL, Turner JR. The tight junction in inflammatory disease: communication breakdown. Curr. Opin. Pharmacol.<\/i>, 9<\/b>, 715\u2013720 (2009)."},{"key":"40","unstructured":"40) Spinelli A, Correale C, Szabo H, Montorsi M. Intestinal fibrosis in Crohn\u2019s disease: medical treatment or surgery? Curr. Drug Targets<\/i>, 11<\/b>, 242\u2013248 (2010)."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J. Biol. Chem.<\/i>, 285<\/b>, 20202\u201320212 (2010).","DOI":"10.1074\/jbc.M110.102012"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest.<\/i>, 117<\/b>, 514\u2013521 (2007).","DOI":"10.1172\/JCI30587"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Kasendra M, Tovaglieri A, Sontheimer-Phelps A, Jalili-Firoozinezhad S, Bein A, Chalkiadaki A, Scholl W, Zhang C, Rickner H, Richmond CA, Li H, Breault DT, Ingber DE. Development of a primary human small intestine-on-a-chip using biopsy-derived organoids. Sci. Rep.<\/i>, 8<\/b>, 2871 (2018).","DOI":"10.1038\/s41598-018-21201-7"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Workman MJ, Gleeson JP, Troisi EJ, Estrada HQ, Kerns SJ, Hinojosa CD, Hamilton GA, Targan SR, Svendsen CN, Barrett RJ. Enhanced utilization of induced pluripotent stem cell-derived human intestinal organoids using microengineered chips. Cell. Mol. Gastroenterol. Hepatol.<\/i>, 5<\/b>, 669\u2013677.e2 (2018).","DOI":"10.1016\/j.jcmgh.2017.12.008"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/7\/43_b20-00088\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T03:18:43Z","timestamp":1593832723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/7\/43_b20-00088\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00088","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}